Skip to main content
SpringerLink
Log in

Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The effects of hematuria on the outcome of IgA nephropathy (IgAN) remain unknown and treatment of IgAN with severe hematuria is controversial.

Methods

Eighty-eight IgAN patients with proteinuria <0.5 g/day and who had not received corticosteroids, immunosuppressive agents, or undergone a tonsillectomy were divided into two groups: (1) patients with low (<20/high-power field [HPF]) urinary red blood cell (U-RBC) counts (L-RBC group, n = 48); and (2) patients with high (≥20/HPF) U-RBC counts (H-RBC group, n = 40). Clinical and histological findings, renal survival rate and risk factors for progression were analyzed.

Results

The male ratio and blood pressure were significantly higher in the L-RBC group. Median proteinuria, mean estimated glomerular filtration rate and histological findings according to Oxford classifications were similar. During the 5 years after renal biopsy, the median amount of proteinuria remained at <0.5 g/day or g/g creatinine in both groups, and the median U-RBC decreased to <10/HPF in both groups without any intensive therapy. The 15-year renal survival rate, estimated using the Kaplan–Meier method, was 100 % in the H-RBC group, but decreased to 83.4 % in the L-RBC group, although it was not significant. The treatment of inhibitors of renin–angiotensin system (RAS inhibitors) decreased the risk for progression by Cox regression analysis (hazard ratio: 0.14, p = 0.027).

Conclusion

Severe hematuria at the time of biopsy naturally improved without any intensive therapy, and there were no negative effects of hematuria on the outcome of IgAN with mild proteinuria. Its prognosis was relatively good, and the treatment of RAS inhibitors might prevent from progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9:e91756.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analysis. Am J Kidney Dis. 1991;18:12–9.

    Article  CAS  PubMed  Google Scholar 

  3. Koyama A, Igarashi M, Kobayashi M. Coworkers of the research group on progressive renal disease: natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29:526–32.

    Article  CAS  PubMed  Google Scholar 

  4. Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27:1479–85.

    Article  CAS  PubMed  Google Scholar 

  5. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ. Mortality of IgA nephropathy patients: a single center experience over 30 years. PLoS One. 2012;7:e51225.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Jalalah SM, Alzahrani IH, Furness PN. Glomerular changes in microscopic hematuria, studied by quantitative immunoelecton microscopy and in situ zymography. Nephrol Dial Transplant. 2002;17:2586–93.

    Article  Google Scholar 

  7. Rauta V, Finne P, Fagerudd J, Rosenlof K, Tornroth T, Gronhagen-Riska C. Factors associated with progression IgA nephropathy are related to renal function-a model for estimating risk of progression in mild disease. Clin Nephrol. 2002;58:85–94.

    Article  CAS  PubMed  Google Scholar 

  8. Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, Tomino Y, Matsuo S. Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol. 2014;18:481–6.

    Article  CAS  PubMed  Google Scholar 

  9. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D’Agati V, D’Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–45.

    Article  PubMed  Google Scholar 

  10. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology, definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–56.

    Article  PubMed  Google Scholar 

  11. Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001;110:434–7.

    Article  CAS  PubMed  Google Scholar 

  12. Shen P, He L, Li Y, Wang Y, Chan M. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract. 2007;106:157–61.

    Article  Google Scholar 

  13. Shen P, He L, Huang D. Clinical course and prognostic factors of clinically early IgA nephropathy. Neth J Med. 2008;66:242–7.

    CAS  PubMed  Google Scholar 

  14. Harmankaya Ö, Öztürk Y, Baştürk T, Öbek A, Kılıçarslan I. Efficacy of immunsuppressivetherapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol. 2002;33:167–71.

    Article  CAS  PubMed  Google Scholar 

  15. Manno C, Strippoli GFN, D’Alti C, Torres D, Rossini M, Schena FP. A novel simplar histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007;49:763–75.

    Article  PubMed  Google Scholar 

  16. Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M, Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN). Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol. 2012;23:1753–60.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kim BS, Kim YK, Shin YS, Kim YO, Song HC, Kim YS, Choi EJ. Natural history and renal pathology in patients with isolated microscopic hematuria. Korean J Intern Med. 2009;24:356–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

  1. Department of Medicine, Kidney Center, Tokyo Women’s Medical University, Kawada-cho 8-1, Shinjyuku-ku, Tokyo, 162-8666, Japan

    Kayu Tanaka, Takahito Moriyama, Chihiro Iwasaki, Takashi Takei & Kosaku Nitta

Authors
  1. Kayu Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takahito Moriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chihiro Iwasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Takei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kosaku Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takahito Moriyama.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanaka, K., Moriyama, T., Iwasaki, C. et al. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria. Clin Exp Nephrol 19, 815–821 (2015). https://doi.org/10.1007/s10157-014-1068-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-014-1068-9

Keywords

Search

Navigation